Switching from WhiteLabelMD?
The WhiteLabelMD alternative whose rate does not rise when your prices do.
WhiteLabelMD brokers the whole launch (providers, pharmacy, labs, compliance) and gets paid as a share of what you sell. EmbedCare operates the same layers on flat product rates fixed in a signed partner agreement. Both are done-for-you; the difference is what happens to your unit economics on the day the program works.
A revenue share ties your vendor's take to what you charge. A flat rate fixes it per product, so the spread you build stays yours.
EmbedCare vs WhiteLabelMD, model by model
WhiteLabelMD positions as done-for-you turnkey telehealth launches on a revenue-share model. Here's where the models differ.
| Dimension | WhiteLabelMD | EmbedCare |
|---|---|---|
| Clinician workforce | Brokered: its terms say it provides “access to a network of licensed providers”; board-certified, all 50 states (its claim); physician/NP mix not stated | Credentialed 50-state network, routed on an SLA. One contract |
| Pharmacy supply | 503A/503B partners, not owned; pass-through cost with no markup (its claim); no pharmacy named | Owned pharmacy supply network: integrated compounding pharmacies |
| Storefront & funnel | Included: branded storefront, packaging, inserts; markets a launch in about 30 days | Included: white-label storefront + intake on your domain |
| Conversion & retention engine | Marketing, analytics, and patient support offered, in a full-service or hybrid model (its claims) | Shipped: funnels, SMS/email, refills, winback |
| Compliance operations | “Official LegitScript Enterprise Partner” (its claim, corroborated on LegitScript’s own site); HIPAA claimed; no SOC 2 or BAA claim on its site | Operated: LegitScript, HIPAA, state prescribing |
| Contract shape | Revenue share, “not heavy upfront fees”; percentage, minimums, and term all unpublished at the Sept 8, 2026 check | Flat product rates; your margin flexes, ours doesn't |
| Brand & data ownership | Yours, per its FAQ: “The brand, the patients, and the data are yours” | Yours: brand, patients, and data stay with you |
Comparison is model-level, based on each vendor's public positioning as of September 2026; capabilities, pricing, and terms change; verify independently before relying on any statement here. Pricing observations describe what vendors publish or publicly market, not private quotes. All trademarks belong to their owners; EmbedCare is not affiliated with or endorsed by any vendor named.
WhiteLabelMD pricing
WhiteLabelMD publishes no figures at all: a sweep of its site on September 8, 2026 found zero dollar amounts on any page. What it publishes instead is a model. Its FAQ says startup costs “vary based on your business model and scale” and that it offers “flexible pricing models”; its homepage says “Our model is revenue share, not heavy upfront fees. We get paid when your patients pay” and “Pass-through pricing, zero markup. No hidden margins on medications or fulfillment.” The percentage, any floor or minimum, and the contract term are all unpublished, so the number that decides your economics is the one you have to ask for. Get the percentage, the base it applies to, and the term in writing, then model it at the volume you intend to reach rather than the volume you start at.
EmbedCare prices the operated stack as flat product rates fixed in your partner agreement, with medication included on GLP-1 programs and a self-serve Launch tier starting at $495/mo. Be precise about what differs, because both models cost more in total as you add patients: that part is the same. What a revenue share does is take a cut of each patient's spend, so it rises again every time you raise retail or a patient adds a product, and your margin is capped at whatever slice is left. A flat rate is fixed per product, so the spread between it and your retail is yours to set and yours to keep. Which is cheaper depends entirely on how well the program works and on the percentage you are quoted, so run both against your own twelve-month projection rather than against launch month.
WhiteLabelMD reviews
Third-party review coverage of WhiteLabelMD is thin: B2B telehealth infrastructure is bought through demos and references, not review marketplaces, so G2, Capterra, and Trustpilot listings in this category are sparse or unclaimed. Search those platforms for the current state, then weigh reference calls more heavily than star counts.
Its Trustpilot profile existed but was unclaimed with zero reviews at a September 8, 2026 check, and no G2 or Capterra listing surfaced. The one named third-party corroboration is LegitScript’s own customer-spotlight page, which quotes CEO Justin Champion and says WhiteLabelMD has “helped over 100 telehealth and telemedicine businesses expedite their LegitScript certification.” Read it as partnership confirmation rather than as a review: a certifier promoting a partner is not an operator reporting an outcome, and the page carries no date.
Whichever vendor you pick, ask for two reference calls with operators at your volume, and ask both the same three questions: what does a fill actually cost you all-in, who owns the patient record if you leave, and what happened the last time something broke on a Friday.
Top WhiteLabelMD alternatives
The vendors operators actually shortlist in this category, by public positioning as of September 2026. Start with the model question (software, network, or operated stack), then compare rates in writing.
Turnkey, operated white-label telehealth: 50-state clinicians, owned pharmacy supply, storefront, retention, and compliance on flat product rates.
See the platformClinician staffing plus admin services for telehealth programs, with a large launch-a-vertical content library.
vs EmbedCarePhysician-led end-to-end network: 50-state clinicians plus pharmacy and lab fulfillment behind your brand.
vs EmbedCareAPI-first asynchronous visits and Rx routing for teams that want to build their own stack.
vs EmbedCareClinician workforce infrastructure as an API, aimed at digital health companies and enterprises.
vs EmbedCareEnterprise virtual-care platform plus clinician network, increasingly focused on health systems and pharma.
vs EmbedCareWhite-label care programs combining clinicians, pharmacy, labs, and workflow automation.
vs EmbedCareSelf-serve white-label software for peptide and GLP-1 programs with a partner provider network.
vs EmbedCareFlat-fee white-label telehealth for DTC founders; positions on no revenue share, with from-pricing published on its marketing pages.
vs EmbedCareDeveloper-leaning telehealth commerce platform: storefront builder, payments, EMR/e-prescribe, pharmacy network.
vs EmbedCareWhite-label telehealth infrastructure with published per-consult and monthly platform pricing.
vs EmbedCareLower-cost white-label storefront, checkout, and pharmacy fulfillment under your own domain.
vs EmbedCareTurnkey white-label GLP-1 and wellness programs aimed at med spas, gyms, and local businesses.
vs EmbedCareAPI-first multi-vertical white-label infrastructure with adaptive intake and e-prescribing.
vs EmbedCareEHR and practice software for clinician-led virtual practices rather than white-label brands.
vs EmbedCareProvider network and DTC program infrastructure, oriented to retail and enterprise partners.
vs EmbedCareWhite-label patient-access software for organizations that already have clinicians; not a healthcare provider by its own terms.
vs EmbedCarePay-per-consult good-faith exams and prescriptions for med spas and clinics, with published per-exam pricing.
vs EmbedCareMembership-based good-faith-exam compliance service for med spas, staffed by W-2 nurse practitioners.
vs EmbedCareTurnkey white-label GLP-1 clinic launches on an MSO structure; a 2025 entrant with sales-quoted pricing.
vs EmbedCareWhite-label telehealth and EHR for entrepreneurs and coaches, with clinicians from a named third-party network and public release notes.
vs EmbedCareThis is the margin running through your stack.
Every layer you rent (workforce fees, marked-up fills, platform take) comes out of this number. Owned pharmacy supply and flat product rates give the spread back to you.
Margin Engine
Set your active patients. This is the margin running through your stack.
Modeled on a representative blended program mix across care lines. DTC GLP-1 subscriptions alone run ~$199/mo in the market. Illustrative estimate only; actual results vary with mix, retention, pricing, and medication costs. Not guaranteed earnings.
Switch without a rebuild.
- 01
Connect
We integrate with your existing storefront, intake, and funnel. Everything your patients see stays exactly as it is.
- 02
Parallel-run
Route a slice of volume through Embed (same patients, new economics) and compare the per-fill math side by side.
- 03
Cut over
Move the book when the numbers win. Add care lines when you're ready.
If you are pre-revenue and want your vendor paid only when you actually sell something, a revenue share is a rational way to de-risk a launch, and it is the honest case for staying. Its LegitScript enterprise-partner position is the other: if getting ads and card processing turned on is what stands between you and revenue, a vendor whose business is compressing that timeline may be worth the share. The switch case arrives later and predictably, on the day the program works and the share starts costing more than an operated stack on flat rates would.
WhiteLabelMD: what operators ask
What are the best WhiteLabelMD alternatives?
Done-for-you peers first, since that is the actual category: EmbedCare (operated stack, owned pharmacy supply, flat product rates), LegUpRx, RxPNow, and CareValidate. Beluga Health is the adjacent end-to-end network. Self-serve software (Karpa, Rimo, Cuvo, Bask) is a different purchase entirely: those hand you tools and leave the operating to you, which is the opposite of what WhiteLabelMD sells.
How much does WhiteLabelMD cost?
It published no dollar figures anywhere on its site as of September 8, 2026. It states a model instead: revenue share rather than heavy upfront fees, with medication and fulfillment passed through at cost and no markup. The share percentage, any minimum, and the contract term are not published, so ask for all three in writing. Then model the share against your twelve-month target, because a revenue share is cheapest exactly when the program is not working and most expensive when it is.
Does WhiteLabelMD provide the doctors?
Not as its own medical group. Its Terms of Service say it provides “access to a network of licensed providers” and that WhiteLabelMD “does not practice medicine, does not dispense medication, and does not provide medical advice.” Its FAQ puts it plainly: “our licensed provider network handles clinical care and prescribing across all 50 states. You own the brand; we handle the medicine.” It claims board-certified providers in all 50 states; the physician and NP mix is not stated, which is a fair question for a scoping call.
How is EmbedCare different from WhiteLabelMD?
Same promise, different compensation and different supply. Both run the launch for you; WhiteLabelMD brokers providers and 503A/503B pharmacy partners and takes a share of revenue, while EmbedCare operates 50-state clinicians and owned pharmacy supply on flat product rates fixed in your agreement, with medication included on GLP-1 programs. Two things to weigh honestly: a flat rate protects your margin as you scale where a share does not, and WhiteLabelMD holds a LegitScript enterprise partnership that we do not, which is a real advantage if certification speed is your binding constraint.
Comparing WhiteLabelMD? Get the partner overview and start the switching conversation.
One email, no sequence. A human follows up with your program scoped.